Let-7a elevates p21WAF1 levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells

FEBS Letters

Volumn 583, Issue 21, 2009, Pages 3501-3507

  He, Xiaoyan ^a   Duan, Changzhu ^a   Chen, Junxia ^a   Ou Yang, Xi ^a   Zhang, Zheng ^a   Li, Chunlei ^a   Peng, Huimin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Let 7a; Lung cancer; MicroRNA; NIRF; p21WAF1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; MICRORNA; MICRORNA LET 7A; NP95 ICBP90 RING FINGER PROTEIN; RING FINGER PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CONTROL; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COMPUTATIONAL BIOLOGY; CONSERVED SEQUENCE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICRORNAS; PHYLOGENY; UBIQUITIN-PROTEIN LIGASES;

EID: 70350326303     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.10.007     Document Type: Article

References (24)

1. Lewis B.P., Burge C.B., and Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005) 15-20
2. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., and Golub T.R. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
3. Jay C., Nemunaitis J., Chen P., Fulgham P., and Tong A.W. MiRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol. 26 (2007) 293-300
4. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., Horvitz H.R., and Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403 (2000) 901-906
5. Pasquinelli A.E., Reinhart B.J., Slack F., Martindale M.Q., Kuroda M.I., Maller B., Hayward D.C., Ball E.E., Degnan B., Müller P., Spring J., Srinivasan A., Fishman M., Finnerty J., Corbo J., Levine M., Leahy P., Davidson E., and Ruvkun G. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408 (2000) 86-89
6. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., Harano T., Yatabe Y., Nagino M., Nimura Y., Mitsudomi T., and Takahashi T. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64 (2004) 3753-3756
7. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K.L., Brown D., and Slack F.J. RAS is regulated by the let-7 microRNA family. Cell 120 (2005) 635-647
8. Mayr C., Hemann M.T., and Bartel D.P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315 (2007) 1576-1579
9. Lee Y.S., and Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 21 (2007) 1025-1030
10. Koscianska E., Baev V., Skreka K., Oikonomaki K., Rusinov V., Tabler M., and Kalantidis K. Prediction and preliminary validation of oncogene regulation by miRNAs. BMC Mol. Biol. 8 (2007) 79
11. Meng F., Henson R., Wehbe-Janek H., Smith H., Ueno Y., and Patel T. The microRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. J. Biol. Chem. 282 (2007) 8256-8264
12. Johnson C.D., Esquela-Kerscher A., Stefani G., Byrom M., Kelnar K., Ovcharenko D., Wilson M., Wang X., Shelton J., Shingara J., Chin L., Brown D., and Slack F.J. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res. 67 (2007) 7713-7722
13. Megraw M., Sethupathy P., Corda B., and Hatzigeorgiou A.G. MiRGen: a database for the study of animal microRNA genomic organization and function. Nucleic Acids Res. 35 (2007) D149-D155
14. Doench J.G., Petersen C.P., and Sharp P.A. SiRNAs can function as miRNAs. Genes Dev. 17 (2003) 438-442
15. Hua Z., Lv Q., Ye W., Wong C.K., Cai G., Gu D., Ji Y., Zhao C., Wang J., Yang B.B., and Zhang Y. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 1 (2006) e116
16. Bronner C., Achour M., Arima Y., Chataigneau T., Saya H., and Schini-Kerth V.B. The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?. Pharmacol. Ther. 115 (2007) 419-434
17. Daniely M., Aviram A., Adams E.F., Buchfelder M., Barkai G., Fahlbusch R., Goldman B., and Friedman E. Comparative genomic hybridization analysis of nonfunctioning pituitary tumors. J. Clin. Endocrinol. Metab. 83 (1998) 1801-1805
18. Joos S., Küpper M., Ohl S., von Bonin F., Mechtersheimer G., Bentz M., Marynen P., Möller P., Pfreundschuh M., Trümper L., and Lichter P. Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res. 60 (2000) 549-552
19. Oga A., Kong G., Tae K., Lee Y., and Sasaki K. Comparative genomic hybridization analysis reveals 3q gain resulting in genetic alteration in 3q in advanced oral squamous cell carcinoma. Cancer Genet. Cytogenet. 127 (2001) 24-29
20. Mori T., Li Y., Hata H., Ono K., and Kochi H. NIRF, a novel RING finger protein, is involved in cell-cycle regulation. Biochem. Biophys. Res. Commun. 296 (2002) 530-536
21. Lai E.C. MicroRNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat. Genet. 30 (2002) 363-364
22. Unoki M., Nishidate T., and Nakamura Y. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene 23 (2004) 7601-7610
23. Gui C.Y., Ngo L., Xu W.S., Richon V.M., and Marks P.A. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc. Natl. Acad. Sci. USA 101 (2004) 1241-1246
24. Chen J.S., and Faller D.V. Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts. J. Cell. Physiol. 202 (2005) 87-99